Ganymed Robotics

Ganymed Robotics is a private, Paris-based MedTech startup pioneering a novel approach to surgical robotics for orthopedics. The company's proprietary platform combines advanced computer vision, multimodal sensors, and a co-manipulated robotic arm to enable marker-less, patient-specific knee and joint replacement surgeries. While its lead product for knee replacement is in pre-clinical development and not yet FDA-cleared, the company has secured backing from notable European venture capital firms. Ganymed's vision is to establish a new standard of care by increasing procedural accuracy, improving patient outcomes, and providing a cost-effective, data-generating surgical system.

Proprietary 'robot-with-eyes' platform combining advanced computer vision (multimodal sensors for marker-less, contactless anatomy registration) with a co-manipulated, autonomy-ready robotic arm designed for orthopedic surgery.

Ganymed competes in the crowded and fast-evolving orthopedic robotics market against major players like Stryker (Mako), Zimmer Biomet (ROSA), Johnson & Johnson (Velys, Ottava), and Smith & Nephew (Cori). Its primary differentiation is the elimination of marker-based registration (optical trackers, intramedullary rods), aiming for a more streamlined and less invasive approach compared to these established systems.